229 related articles for article (PubMed ID: 19884343)
1. Impaired lysosomal trimming of N-linked oligosaccharides leads to hyperglycosylation of native lysosomal proteins in mice with alpha-mannosidosis.
Damme M; Morelle W; Schmidt B; Andersson C; Fogh J; Michalski JC; Lübke T
Mol Cell Biol; 2010 Jan; 30(1):273-83. PubMed ID: 19884343
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study.
Roces DP; Lüllmann-Rauch R; Peng J; Balducci C; Andersson C; Tollersrud O; Fogh J; Orlacchio A; Beccari T; Saftig P; von Figura K
Hum Mol Genet; 2004 Sep; 13(18):1979-88. PubMed ID: 15269179
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal alpha-mannosidase and alpha-mannosidosis.
Paciotti S; Codini M; Tasegian A; Ceccarini MR; Cataldi S; Arcuri C; Fioretti B; Albi E; Beccari T
Front Biosci (Landmark Ed); 2017 Jan; 22(1):157-167. PubMed ID: 27814608
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement therapy in alpha-mannosidosis guinea-pigs.
Crawley AC; King B; Berg T; Meikle PJ; Hopwood JJ
Mol Genet Metab; 2006; 89(1-2):48-57. PubMed ID: 16807033
[TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of the lysosomal alpha-mannosidase gene results in mice resembling a mild form of human alpha-mannosidosis.
Stinchi S; Lüllmann-Rauch R; Hartmann D; Coenen R; Beccari T; Orlacchio A; von Figura K; Saftig P
Hum Mol Genet; 1999 Aug; 8(8):1365-72. PubMed ID: 10400983
[TBL] [Abstract][Full Text] [Related]
6. Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice.
Blanz J; Stroobants S; Lüllmann-Rauch R; Morelle W; Lüdemann M; D'Hooge R; Reuterwall H; Michalski JC; Fogh J; Andersson C; Saftig P
Hum Mol Genet; 2008 Nov; 17(22):3437-45. PubMed ID: 18713755
[TBL] [Abstract][Full Text] [Related]
7. Alpha-Mannosidosis: Therapeutic Strategies.
Ceccarini MR; Codini M; Conte C; Patria F; Cataldi S; Bertelli M; Albi E; Beccari T
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772816
[TBL] [Abstract][Full Text] [Related]
8. Direct enzyme transfer from lymphocytes corrects a lysosomal storage disease.
Abraham D; Muir H; Olsen I; Winchester B
Biochem Biophys Res Commun; 1985 Jun; 129(2):417-25. PubMed ID: 4015639
[TBL] [Abstract][Full Text] [Related]
9. The substrate specificity of bovine and feline lysosomal alpha-D-mannosidases in relation to alpha-mannosidosis.
DeGasperi R; al Daher S; Daniel PF; Winchester BG; Jeanloz RW; Warren CD
J Biol Chem; 1991 Sep; 266(25):16556-63. PubMed ID: 1885586
[TBL] [Abstract][Full Text] [Related]
10. The substrate-specificity of human lysosomal alpha-D-mannosidase in relation to genetic alpha-mannosidosis.
al Daher S; de Gasperi R; Daniel P; Hall N; Warren CD; Winchester B
Biochem J; 1991 Aug; 277 ( Pt 3)(Pt 3):743-51. PubMed ID: 1872811
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.
Damme M; Stroobants S; Walkley SU; Lüllmann-Rauch R; D'Hooge R; Fogh J; Saftig P; Lübke T; Blanz J
J Neuropathol Exp Neurol; 2011 Jan; 70(1):83-94. PubMed ID: 21157375
[TBL] [Abstract][Full Text] [Related]
12. A human lysosomal alpha(1----6)-mannosidase active on the branched trimannosyl core of complex glycans.
Daniel PF; Evans JE; De Gasperi R; Winchester B; Warren CD
Glycobiology; 1992 Aug; 2(4):327-36. PubMed ID: 1421754
[TBL] [Abstract][Full Text] [Related]
13. Long-term enzyme replacement therapy improves neurocognitive functioning and hippocampal synaptic plasticity in immune-tolerant alpha-mannosidosis mice.
Stroobants S; Damme M; Van der Jeugd A; Vermaercke B; Andersson C; Fogh J; Saftig P; Blanz J; D'Hooge R
Neurobiol Dis; 2017 Oct; 106():255-268. PubMed ID: 28720484
[TBL] [Abstract][Full Text] [Related]
14. Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase.
Faid V; Evjen G; Tollersrud OK; Michalski JC; Morelle W
Glycobiology; 2006 May; 16(5):440-61. PubMed ID: 16449350
[TBL] [Abstract][Full Text] [Related]
15. The catabolism of mammalian glycoproteins. Comparison of the storage products in bovine, feline and human mannosidosis.
Abraham D; Blakemore WF; Jolly RD; Sidebotham R; Winchester B
Biochem J; 1983 Dec; 215(3):573-9. PubMed ID: 6661184
[TBL] [Abstract][Full Text] [Related]
16. Beta-mannosidosis mice: a model for the human lysosomal storage disease.
Zhu M; Lovell KL; Patterson JS; Saunders TL; Hughes ED; Friderici KH
Hum Mol Genet; 2006 Feb; 15(3):493-500. PubMed ID: 16377659
[TBL] [Abstract][Full Text] [Related]
17. A human lysosomal alpha-mannosidase specific for the core of complex glycans.
De Gasperi R; Daniel PF; Warren CD
J Biol Chem; 1992 May; 267(14):9706-12. PubMed ID: 1577805
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of recombinant human lysosomal alpha-mannosidase.
Berg T; King B; Meikle PJ; Nilssen Ø ; Tollersrud OK; Hopwood JJ
Mol Genet Metab; 2001 May; 73(1):18-29. PubMed ID: 11350179
[TBL] [Abstract][Full Text] [Related]
19. The Application of HPLC-FLD and NMR in the Monitoring of Therapy Efficacy in Alpha-Mannosidosis.
Krchňák M; Kodríková R; Matulová M; Nemčovič M; Uhliariková I; Katrlík J; Šalingová A; Hlavatá A; Juríčková K; Baráth P; Mucha J; Pakanová Z
Front Biosci (Landmark Ed); 2023 Feb; 28(2):39. PubMed ID: 36866557
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of alpha-Mannosidosis: Practical approaches to reducing diagnostic delays in this ultra-rare disease.
Santoro L; Cefalo G; Canalini F; Rossi S; Scarpa M
Mol Genet Metab; 2024 May; 142(1):108444. PubMed ID: 38555683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
